Long-term efficacy and safety of adalimumab in 4-12 year old patients with juvenile idiopathic arthritis

• Wouters C,
• McIlraith MJ,
• Ilowite N,
• Chalom E,
• Jones OY,
• Koné-Paut I,
• Higgins G,
• Gamir M,
• Reiff A,
• Lovell DJ,
• Ruperto N,
• Liu S,
• Kupper H,
• Giannini EH,
• Martini A

Affiliations

Wouters C

McIlraith MJ

Ilowite N

Chalom E

Jones OY

Koné-Paut I

Higgins G

Gamir M

Reiff A

Lovell DJ

Ruperto N

Liu S

Kupper H

Giannini EH

Martini A